Covid-19: Two shot vaccine by Zydus gets SEC nod

Soon a two-shot Covid-19 vaccine of Zydus Cadila could be rolled out, instead of the three-shot regimen currently approved. The company has received approval from the Subject Expert Committee (SEC) under the health ministry, paving the way for a nod by the drug regulator soon, sources told TOI.

source https://timesofindia.indiatimes.com/india/covid-19-two-shot-vaccine-by-zydus-gets-sec-nod/articleshow/90853009.cms